Evidence map›Paper›PMID 38838972›Full record

ReviewExperimental eye research2024

The relationship between dry eye disease and human microbiota: A review of the science.

Gal Antman, Lukas Ritzer, Anat Galor, Alice Verticchio Vercellin, Brent A Siesky, Denise Alabi, Jason Vayner, Fani Segev, Alon Harris

Abstract readReview
In one paragraph

Review in Experimental eye research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Frontiers in nutrition · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gal AntmanDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA; Department of Ophthalmology, Rabin Medical Center, Petach Tikwa, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lukas RitzerDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Anat GalorBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami Veterans Affairs Medical Center, Miami, FL, USA.
Alice Verticchio VercellinDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Brent A SieskyDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Denise AlabiDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Jason VaynerDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Fani SegevOphthalmology, Assuta Ashdod Medical Center, Goldman Medical School, Ben-Gurion University, Be'er Sheva, Israel.
Alon HarrisDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, USA. Electronic address: alon.harris@mssm.edu.

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Differentiation of Clinical Phenotypes of Inflammatory and Neuropathic Ocular Pain Conditions with Morphologic Measures and Functional Brain ImagingU01EY034686 · NEI · BOSTON CHILDREN'S HOSPITAL · PI Eric Alan Moulton · 2022 to 2026
$4.7M
Defining bacterial members of the ocular surface microbiome and assessing stability over timeU24EY035102 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GALOR, ANAT, ST LEGER, ANTHONY J · 2023 to 2025
$3.3M
Tear protein biomarkers of refractive surgery painR33EY032468 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A, GALOR, ANAT · 2023 to 2025
$2.9M
Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamicsR01EY030851 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARCIERO, JULIA, HARRIS, ALON · 2020 to 2023
$1.3M
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factorsR01EY034718 · NEI · UNIVERSITY OF MAINE ORONO · PI GUIDOBONI, GIOVANNA, HARRIS, ALON · 2022 to 2025
$975k
Lipid mediators and their signaling in ocular surface inflammation and meibomian gland dysfunctionI01BX004893 · VA · MIAMI VA HEALTH CARE SYSTEM · PI GALOR, ANAT, MANDAL, NAWAJES · 2021 to 2025
–
A pilot study of the safety and feasibility of transcutaneous electrical nerve stimulation (TENS) for chronic ocular painI21RX003883 · VA · MIAMI VA HEALTH CARE SYSTEM · PI FELIX, ELIZABETH ROY · 2022 to 2023
–
Neural mechanisms underlying photophobia and dry eyeI01CX002015 · VA · MIAMI VA HEALTH CARE SYSTEM · PI Anat Galor · 2020 to 2026
–
BLRD VA I01 BX004893CSRD VA I01 CX002015NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY030851NEI NIH HHS R01 EY034718NEI NIH HHS R33 EY032468NEI NIH HHS U01 EY034686NEI NIH HHS U24 EY035102RRD VA I21 RX003883
6 · The paper itself

Abstract

A complex relationship exists between human microbiota and the risk for ophthalmic disease. While the homeostatic composition of human microbiota is still being established, including what defines dysbiosis (i.e. changes in diversity and abundance), pilot research has begun to identify the potential influence of demographics, geography, and co-morbidities on the microbiota and describe their impact on ocular health. This review specifically focuses on the scientific relationships of the human oral and gut microbiota to dry eye disease (DED), a set of conditions impacting the tear film and ocular surface. Although data are sparse and often conflict across studies, the literature generally supports associations between microbial imbalance (dysbiosis) and DED and alterations in microbial diversity and abundance to specific aspects of DED. This review examines the relevant science and mechanistic relationships linking gut and oral dysbiosis and DED. Various physiochemical factors and therapeutic approaches that alter microbiota, including medications and fecal transplants are examined in relation to DED.

Indexed as

Dry Eye SyndromesDysbiosisGastrointestinal MicrobiomeMicrobiotaHumansMouthTearsBacteriaDry eyeEye diseaseGutMicrobiota

Identifiers

PMID38838972
PMCPMC11250917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.